Literature DB >> 7153707

Immunoselection of tumor cell variants by mice suppressed with ultraviolet radiation.

J L Urban, J M Holland, M L Kripke, H Schreiber.   

Abstract

It has previously been shown that mice exposed to ultraviolet radiation (UV) fail to reject highly immunogenic UV-induced tumors, which are regularly rejected by normal mice. The present study shows, however, that this immunosuppresion is incomplete, as UV-treated mice can still mount certain tumor-specific immune responses and reject smaller inocula of tumor cells that regularly grow progressively in athymic nude mice. Furthermore, all tumor cell lines that were reisolated from the tumor mass resulting from one tumor passage through UV-treated recipients heritably lost a tumor-specific determinant present on the parental tumor cells used for transplantation, and a large percentage of these reisolated variant tumors had changed to progressively growing tumors, in that they were no longer rejected by normal mice. In contrast, none of the tumors reisolated from passage through athymic nude mice or anti-idiotypically suppressed mice showed this change in antigenicity and progressive growth behavior. Thus, it appears that the phenotypic change in tumors reisolated from UV-treated mice was caused by immunoselection, and that the tumor-specific immunity in these mice apparently restrained the outgrowth of the parental tumor cells despite the partial immunosuppression. Because of the regularity at which tumor variants arose in the UV-treated mice after tumor transplantation, it appears that the partial immunosuppression caused by UV-treatment may have favored the outgrowth of antigenic variants from the parental tumor cell population, possibly by allowing more time for the generation of tumor variants. A similar immunoselection process might be part of tumor progression during tumor development and preferentially occur in cancer-bearing individuals showing concomitant tumor immunity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7153707      PMCID: PMC2186818          DOI: 10.1084/jem.156.4.1025

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  23 in total

1.  Cytotoxicity inhibition assay: cryopreservation and standardization: brief communication.

Authors:  R K Oldham; J R Ortaldo; H T Holden; R B Herberman
Journal:  J Natl Cancer Inst       Date:  1977-10       Impact factor: 13.506

2.  Evidence for the generation of suppressor cells by ultraviolet radiation.

Authors:  R A Daynes; C W Spellman
Journal:  Cell Immunol       Date:  1977-06-01       Impact factor: 4.868

3.  Antigenicity of murine skin tumors induced by ultraviolet light.

Authors:  M L Kripke
Journal:  J Natl Cancer Inst       Date:  1974-11       Impact factor: 13.506

4.  Systemic alteration induced in mice by ultraviolet light irradiation and its relationship to ultraviolet carcinogenesis.

Authors:  M S Fisher; M L Kripke
Journal:  Proc Natl Acad Sci U S A       Date:  1977-04       Impact factor: 11.205

5.  Latency, histology, and antigenicity of tumors induced by ultraviolet light in three inbred mouse strains.

Authors:  M L Kripke
Journal:  Cancer Res       Date:  1977-05       Impact factor: 12.701

6.  A biological role for the major histocompatibility antigens.

Authors:  P C Doherty; R M Zinkernagel
Journal:  Lancet       Date:  1975-06-28       Impact factor: 79.321

7.  Ultraviolet light induced murine suppressor lymphocytes dictate specificity of anti-ultraviolet tumor immune responses.

Authors:  C W Spellman; R A Daynes
Journal:  Cell Immunol       Date:  1978-06       Impact factor: 4.868

8.  Studies into the transplantation biology of ultraviolet light-induced tumors.

Authors:  R A Daynes; C W Spellman; J G Woodward; D A Stewart
Journal:  Transplantation       Date:  1977-04       Impact factor: 4.939

9.  Immunologic parameters of ultraviolet carcinogenesis.

Authors:  M L Kripke; M S Fisher
Journal:  J Natl Cancer Inst       Date:  1976-07       Impact factor: 13.506

10.  Induction of partial immunologic tolerance in rats and progressive loss of cellular antigenicity in Gross virus lymphoma.

Authors:  H L Ioachim; S E Keller; B H Dorsett; A Pearse
Journal:  J Exp Med       Date:  1974-06-01       Impact factor: 14.307

View more
  15 in total

1.  Antigen-specific bacterial vaccine combined with anti-PD-L1 rescues dysfunctional endogenous T cells to reject long-established cancer.

Authors:  David C Binder; Boris Engels; Ainhoa Arina; Ping Yu; James M Slauch; Yang-Xin Fu; Theodore Karrison; Byron Burnette; Christian Idel; Ming Zhao; Robert M Hoffman; David H Munn; Donald A Rowley; Hans Schreiber
Journal:  Cancer Immunol Res       Date:  2013-08       Impact factor: 11.151

2.  A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance.

Authors:  G Torre-Amione; R D Beauchamp; H Koeppen; B H Park; H Schreiber; H L Moses; D A Rowley
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

3.  Immunological characterization of tumor-rejection antigens on ultraviolet-light-induced tumors originating in the CB6F1 mouse.

Authors:  T Kitajima; M Iwashiro; K Kuribayashi; S Imamura
Journal:  Cancer Immunol Immunother       Date:  1994-06       Impact factor: 6.968

4.  CD8+ T cells targeting a single immunodominant epitope are sufficient for elimination of established SV40 T antigen-induced brain tumors.

Authors:  Angela M Tatum; Lawrence M Mylin; Susan J Bender; Matthew A Fischer; Beth A Vigliotti; M Judith Tevethia; Satvir S Tevethia; Todd D Schell
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

5.  Identification of a unique tumor-specific antigen as a novel class I major histocompatibility molecule.

Authors:  C Philipps; M McMillan; P M Flood; D B Murphy; J Forman; D Lancki; J E Womack; R S Goodenow; H Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

6.  Malignant growth in the normal host after variant selection in vitro with cytolytic T-cell lines.

Authors:  R D Wortzel; J L Urban; H Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

7.  IFN-gamma- and TNF-dependent bystander eradication of antigen-loss variants in established mouse cancers.

Authors:  Bin Zhang; Theodore Karrison; Donald A Rowley; Hans Schreiber
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

8.  Tumor growth and evasion of immune destruction: UV-induced tumors as a model.

Authors:  C A Mullen; H Schreiber
Journal:  Surv Immunol Res       Date:  1985

9.  Animals bearing malignant grafts reject normal grafts that express through gene transfer the same antigen.

Authors:  G A Perdrizet; S R Ross; H J Stauss; S Singh; H Koeppen; H Schreiber
Journal:  J Exp Med       Date:  1990-04-01       Impact factor: 14.307

10.  Identification of a unique tumor antigen as rejection antigen by molecular cloning and gene transfer.

Authors:  H J Stauss; C Van Waes; M A Fink; B Starr; H Schreiber
Journal:  J Exp Med       Date:  1986-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.